IFNA2 and melanoma: Given that SSG can synergize with interferon-α2b (IFN-α2b), phase I clinical trials studying the combination of SSG and IFN-α2b in the treatment of advanced tumors (NCT00629200) and stage IV melanoma (NCT00498979) were launched and completed in 2018 and 2020, respectively.